Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>		A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.18632/oncotarget.12461

http://scihub22266oqcxt.onion/10.18632/oncotarget.12461
suck pdf from google scholar
C5352108!5352108!27713133
unlimited free pdf from europmc27713133    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi

pmid27713133      Oncotarget 2017 ; 8 (1): 1925-36
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Long non-coding RNAs in anti-cancer drug resistance #MMPMID27713133
  • Chen Qn; Wei Cc; Wang Zx; Sun M
  • Oncotarget 2017[Jan]; 8 (1): 1925-36 PMID27713133show ga
  • Chemotherapy is one of the basic treatments for cancers; however, drug resistance is mainly responsible for the failure of clinical treatment. The mechanism of drug resistance is complicated because of interaction among various factors including drug efflux, DNA damage repair, apoptosis and targets mutation. Long non-coding RNAs (lncRNAs) have been a focus of research in the field of bioscience, and the latest studies have revealed that lncRNAs play essential roles in drug resistance in breast cancer, gastric cancer and lung cancer, et al. Dysregulation of multiple targets and pathways by lncRNAs results in the occurrence of chemoresistance. In this review, we will discuss the mechanisms underlying lncRNA-mediated resistance to chemotherapy and the therapeutic potential of lncRNAs in future cancer treatment.
  • ä


  • DeepDyve
  • Pubget Overpricing

    • suck abstract from ncbi

    Linkout box